Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in ICU patients with sepsis
IRCT20240713062425N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis comparing Melatonin plus standard antibiotic regimen with Placebo plus standard antibiotic regimen (2 arms). Primary endpoint: Prevention of heart damage secondary to sepsis. Started Feb 2025; status: completed.
02
Drugs
melatonin
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20240713062425N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240713062425N1.